Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
440.40
-8.20 (-1.83%)
Aug 14, 2026, 5:29 PM CET
Swedish Orphan Biovitrum AB Employees
Swedish Orphan Biovitrum AB had 2,119 employees as of June 30, 2026. The number of employees increased by 182 or 9.40% compared to the same quarter last year.
Employees
2,119
Change
182
Growth
9.40%
Revenue / Employee
14.45M SEK
Profits / Employee
652.19K SEK
Market Cap
152.94B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 2,119 | 182 | 9.40% |
| Mar 31, 2026 | 1,969 | 74 | 3.91% |
| Dec 31, 2025 | 1,862 | 56 | 3.10% |
| Sep 30, 2025 | 1,890 | 76 | 4.19% |
| Jun 30, 2025 | 1,937 | 165 | 9.31% |
| Mar 31, 2025 | 1,895 | 143 | 8.16% |
| Dec 31, 2024 | 1,806 | 66 | 3.79% |
| Sep 30, 2024 | 1,814 | 23 | 1.28% |
| Jun 30, 2024 | 1,772 | -21 | -1.17% |
| Mar 31, 2024 | 1,752 | 140 | 8.68% |
| Dec 31, 2023 | 1,740 | 184 | 11.83% |
| Sep 30, 2023 | 1,791 | 236 | 15.18% |
| Jun 30, 2023 | 1,793 | 239 | 15.38% |
| Mar 31, 2023 | 1,612 | 43 | 2.74% |
| Dec 31, 2022 | 1,556 | -3 | -0.19% |
| Sep 30, 2022 | 1,555 | 23 | 1.50% |
| Jun 30, 2022 | 1,554 | 17 | 1.11% |
| Mar 31, 2022 | 1,569 | 61 | 4.05% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 251 |
| Orexo AB | 61 |
| EQL Pharma AB | 23 |
| Enzymatica AB | 18 |
| Cinclus Pharma Holding AB | 17 |
| Nanexa AB | 16 |
| Cereno Scientific AB | 10 |
| Moberg Pharma AB | 5 |
Swedish Orphan Biovitrum AB News
- 5 days ago - Innate Pharma Jumps After Sobi Deal To Advance Lacutamab Into Phase 3; Appoints Markus Jensen As CMO - Nasdaq
- 5 days ago - Sobi, Innate Join To Conduct TELLOMAK-3 Phase 3 Confirmatory Trial In Cutaneous T-cell Lymphoma - Nasdaq
- 12 days ago - BioNTech says Sobi's Oelkers will replace Sahin as CEO - Reuters
- 25 days ago - Swedish Orphan Biovitrum price target raised to SEK 515 at Deutsche Bank - TheFly
- 4 weeks ago - Swedish Orphan Biovitrum price target raised to SEK 575 at Berenberg - TheFly
- 4 weeks ago - Biovitrum price target raised to SEK 575 from SEK 550 at H.C. Wainwright - TheFly
- 4 weeks ago - Swedish Orphan Biovitrum downgraded to Hold from Buy at DNB Carnegie - TheFly
- 4 weeks ago - Swedish Orphan Biovitrum AB Earnings Call Transcript: Q2 2026 - Transcripts